Opus Genetics Inc. (OCUP)
NASDAQ
6.07
+0.34 (+5.93%)
Closed
Sep 10, 2026
Day's Range
5.426.22
52 wk Range
1.327.07
Financial Statements - OCUP - Opus Genetics Inc.
Revenue
19.04M
Net Income
-9.98MNet Margin -52.4%
EBITDA
-10.04M
Free Cash Flow
-1.11M
Income Statement
| Period Ending | 2023-12-31 |
|---|---|
| Sales | 19.04M |
| Cost of Goods | - |
| Gross Profit | - |
 Operating Expense | - |
| Operating Income | -10.56M |
| Non-Operating Interest | - |
| Other Income Expense | 1.91M |
| Pre Tax Income | -9.97M |
| Income Tax | 12K |
| Net Income | -9.98M |
| EPS Basic | -0.46 |
| EPS Diluted | -0.46 |
| Basic Shares Outstanding | 21.58M |
| Diluted Shares Outstanding | 21.58M |
| Ebit | -9.97M |
| Ebitda | -10.04M |
| Net Income Continuous Operations | -9.98M |
| Minority Interests | - |
| Preferred Stock Dividends | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
